Pfizer announced Thursday it applied to the Food and Drug Administration (FDA) for approval of its vaccine for 5-11-year-olds — a significant move, as no coronavirus vaccine has been approved for children younger than 12.
The FDA advisory committee is expected to discuss Pfizer’s application on October 26.
The application comes on the heels of Pfizer’s announcement last month, reporting its vaccine to be effective for kids in the younger age bracket:
For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill